Business Context and Reporting Period
This Form 8-K filing by The Chemours Company (CC) was submitted on October 28, 2025. The report discloses the adoption of a new Executive Severance Policy effective as of the filing date.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on corporate governance and executive compensation arrangements.
Material Changes
The primary material change is the Board of Directors' approval of "The Chemours Company Executive Severance Policy." This policy establishes specific payment structures for executive officers and designated employees upon involuntary termination without Cause or resignation for Good Reason. The policy does not supersede existing change in control agreements or alter the treatment of outstanding equity awards.
Guidance, Outlook, and Management Commentary
The filing contains no forward-looking guidance, financial outlook, or general management commentary regarding business operations. The document details the terms of the new severance policy, which requires participants to execute a release of claims to be eligible for benefits.
Severance Policy Terms
- Accrued Obligations: All participants receive accrued base salary, bonus/incentive compensation, and vacation pay.
- CEO Cash Severance: 2.0 times the sum of base salary, target annual incentive opportunity, and annualized health care subsidy.
- Other Executives Cash Severance: 1.0 times the sum of base salary, target annual incentive opportunity, and annualized health care subsidy.
- Prorated Incentive: Annual incentive awards are prorated based on actual performance and months worked.
Investor Verification Checklist
- Verify the specific list of employees designated as "Participants" under the new policy.
- Review the full text of the attached Exhibit 10.1 for definitions of "Cause" and "Good Reason."
- Confirm the status of any existing change in control agreements to ensure they remain in effect alongside this new policy.
- Check for any subsequent filings regarding the execution of releases by current executive officers.